Published in Drug Test Anal on May 24, 2013
Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction (2012) 3.11
'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom (2009) 2.86
Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom (2010) 2.19
A case of a distinct difference between the measured blood ethanol concentration and the concentration estimated by Widmark's equation. Med Sci Law (2013) 1.94
Chinese slimming capsules containing sibutramine sold over the Internet: a case series. Dtsch Arztebl Int (2009) 1.64
ESI-MS/MS library of 1,253 compounds for application in forensic and clinical toxicology. Anal Bioanal Chem (2009) 1.56
Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. J Mass Spectrom (2011) 1.42
Cocktail approach for in vivo phenotyping of 5 major CYP450 isoenzymes: development of an effective sampling, extraction, and analytical procedure and pilot study with comparative genotyping. J Clin Pharmacol (2011) 1.41
Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol Clin Exp Res (2011) 1.33
Measurement of direct ethanol metabolites suggests higher rate of alcohol use among pregnant women than found with the AUDIT--a pilot study in a population-based sample of Swedish women. Am J Obstet Gynecol (2008) 1.26
Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.17
Ethyl glucuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders. Alcohol Alcohol (2004) 1.17
Ethyl glucuronide--the direct ethanol metabolite on the threshold from science to routine use. Addiction (2003) 1.16
Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. Addiction (2006) 1.15
Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports. Addict Biol (2010) 1.15
Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). J Med Toxicol (2011) 1.09
Kinetics in serum and urinary excretion of ethyl sulfate and ethyl glucuronide after medium dose ethanol intake. Int J Legal Med (2007) 1.06
Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days. Alcohol Clin Exp Res (2012) 1.06
Fatal and severe codeine intoxication in 3-year-old twins--interpretation of drug and metabolite concentrations. Int J Legal Med (2009) 1.03
Driving under the influence of synthetic cannabinoids ("Spice"): a case series. Int J Legal Med (2013) 0.99
Forensic confirmatory analysis of ethyl sulfate--a new marker for alcohol consumption--by liquid-chromatography/electrospray ionization/tandem mass spectrometry. J Am Soc Mass Spectrom (2004) 0.99
Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics. Drug Test Anal (2014) 0.97
Concentration of fatty acid ethyl esters in hair of alcoholics: comparison to other biological state markers and self reported-ethanol intake. Alcohol Alcohol (2003) 0.97
Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics. J Mass Spectrom (2013) 0.97
Emerging biomarkers: new directions and clinical applications. Alcohol Clin Exp Res (2005) 0.97
Acute intoxication by synthetic cannabinoids--four case reports. Drug Test Anal (2013) 0.97
Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports. Alcohol Clin Exp Res (2008) 0.96
On sensitivity, specificity, and the influence of various parameters on ethyl glucuronide levels in urine--results from the WHO/ISBRA study. Alcohol Clin Exp Res (2004) 0.96
[Differential diagnostics of stomach contents showing blue discoloration]. Arch Kriminol (2011) 0.95
Stability of ethyl glucuronide in urine, post-mortem tissue and blood samples. Int J Legal Med (2005) 0.95
Anorectic sibutramine detected in a Chinese herbal drug for weight loss. Forensic Sci Int (2006) 0.94
The usefulness of direct ethanol metabolites in assessing alcohol intake in nonintoxicated male patients in an emergency room setting. Alcohol Clin Exp Res (2008) 0.94
Continuous microfluidic DNA extraction using phase-transfer magnetophoresis. Lab Chip (2010) 0.93
Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism. J Mass Spectrom (2013) 0.92
LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal Bioanal Chem (2010) 0.91
Time dependence of elimination of different PEth homologues in alcoholics in comparison with social drinkers. Alcohol Clin Exp Res (2013) 0.90
2-methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques. Anal Bioanal Chem (2013) 0.90
In vitro study of bacterial degradation of ethyl glucuronide and ethyl sulphate. Int J Legal Med (2008) 0.89
Ethanol concentration in breastmilk after the consumption of non-alcoholic beer. Breastfeed Med (2013) 0.89
LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows. Anal Bioanal Chem (2013) 0.89
Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.88
On-line SPE LC-MS/MS for the quantification of Δ9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem (2011) 0.88
Urinary ethyl glucuronide (EtG) and ethyl sulphate (EtS) assessment: valuable tools to improve verification of abstention in alcohol-dependent patients during in-patient treatment and at follow-ups. Addiction (2009) 0.88
Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J Mass Spectrom (2012) 0.87
Urine tested positive for ethyl glucuronide after trace amounts of ethanol. Addiction (2009) 0.86
Survival of severe amlodipine intoxication due to medical intensive care. Forensic Sci Int (2006) 0.86
Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry. Drug Test Anal (2012) 0.86
Progress in monitoring alcohol consumption and alcohol abuse by phosphatidylethanol. Bioanalysis (2014) 0.85
Effect of hair care and hair cosmetics on the concentrations of fatty acid ethyl esters in hair as markers of chronically elevated alcohol consumption. Forensic Sci Int (2003) 0.85
Determination of ethyl glucuronide in human hair by SPE and LC-MS/MS. Forensic Sci Int (2002) 0.85
Bioanalysis of new designer drugs. Bioanalysis (2010) 0.84
Comparison of product ion spectra obtained by liquid chromatography/triple-quadrupole mass spectrometry for library search. Rapid Commun Mass Spectrom (2004) 0.83
Drug dosing error with drops: severe clinical course of codeine intoxication in twins. Eur J Pediatr (2008) 0.83
Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS. J Mass Spectrom (2007) 0.83
Determination of basic drugs of abuse in human serum by online extraction and LC-MS/MS. Anal Bioanal Chem (2009) 0.83
Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.82
Influence of preservatives on the stability of ethyl glucuronide and ethyl sulphate in urine. Forensic Sci Int (2008) 0.82
Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice. PLoS One (2011) 0.82
Validated quantitation of angiotensin II receptor antagonists (ARA-II) in human plasma by liquid-chromatography-tandem mass spectrometry using minimum sample clean-up and investigation of ion suppression. Ther Drug Monit (2007) 0.82
Electrospray-ionization MS/MS library of drugs as database for method development and drug identification. Forensic Sci Int (2006) 0.82
Functional residual capacity measurement by heptafluoropropane in ventilated newborn lungs: in vitro and in vivo validation. Crit Care Med (2006) 0.82
Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB₁. Arch Toxicol (2013) 0.82
[What ethanol metabolites as biological markers tell us about alcohol use]. Wien Med Wochenschr (2013) 0.82
Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system. Forensic Sci Int (2012) 0.82
Hydrolysis and transesterification reactions of candesartan cilexetil observed during the solid phase extraction procedure. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.81
Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke. Drug Test Anal (2013) 0.81
Quantitative determination of the calcium channel antagonists amlodipine, lercanidipine, nitrendipine, felodipine, and lacidipine in human plasma using liquid chromatography-tandem mass spectrometry. Ther Drug Monit (2005) 0.81
Inhibition of bacterial degradation of EtG by collection as dried urine spots (DUS). Anal Bioanal Chem (2012) 0.80
Distribution of ethyl glucuronide in rib bone marrow, other tissues and body liquids as proof of alcohol consumption before death. Forensic Sci Int (2005) 0.80
Characterization of sialic acid index of plasma apolipoprotein J and phosphatidylethanol during alcohol detoxification--a pilot study. Alcohol Clin Exp Res (2011) 0.80
Determination of ethyl glucuronide and ethyl sulfate from dried blood spots. Int J Legal Med (2013) 0.79
Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'. J Mass Spectrom (2012) 0.79
Mutagenic activity of structurally related oxiranes and siloranes in Salmonella typhimurium. Mutat Res (2002) 0.79
Hair analysis for Delta9-tetrahydrocannabinolic acid A--new insights into the mechanism of drug incorporation of cannabinoids into hair. Forensic Sci Int (2010) 0.79
Urine tested positive for ethyl glucuronide and ethyl sulfate after the consumption of yeast and sugar. Forensic Sci Int (2010) 0.79
Urine tested positive for ethyl glucuronide and ethyl sulphate after the consumption of "non-alcoholic" beer. Forensic Sci Int (2010) 0.79
Simultaneous determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. J Mass Spectrom (2004) 0.79
Quality evaluation of tandem mass spectral libraries. Anal Bioanal Chem (2011) 0.79
Development of an LC-MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.79
Optimizing heroin-assisted treatment (HAT): assessment of the contribution of direct ethanol metabolites in identifying hazardous and harmful alcohol use. Drug Alcohol Depend (2010) 0.79
Development and validation of an LC-MS/MS method for quantification of Δ9-tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair. J Mass Spectrom (2013) 0.78
World Health Organization/International Society for Biomedical Research on Alcoholism study on state and trait markers of alcohol use and dependence: back to the future. Alcohol Clin Exp Res (2005) 0.78
Instability of calcium channel antagonists during sample preparation for LC-MS-MS analysis of serum samples. Forensic Sci Int (2006) 0.78
A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization. J Mass Spectrom (2014) 0.78
Tako-tsubo cardiomyopathy: reversible heart failure with favorable outcome in patients with intracerebral hemorrhage. Case report. J Neurosurg (2006) 0.77
Analysis of synthetic cannabinoids in abstinence control: long drug detection windows in serum and implications for practitioners. Drug Test Anal (2013) 0.77
Pharmacokinetics of GHB and detection window in serum and urine after single uptake of a low dose of GBL - an experiment with two volunteers. Drug Test Anal (2013) 0.77
Assessment of the stability of the ethanol metabolite ethyl sulfate in standardised degradation tests. Forensic Sci Int (2009) 0.77
Computer assisted modeling of ethyl sulfate pharmacokinetics. Forensic Sci Int (2009) 0.77